Skip to main content

AZ

Stock
Industrials
Aerospace & Defense

Performance overview

AZ Price
Price Chart

Forward-looking statistics

Beta
0.81
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

a2z technologies canada corp. provides services in the field of advanced engineering capabilities to the military/security markets in israel. the company also develops products for the civilian population; and offers fuel tank intelligent containment system, a capsule that can be placed in a fuel tank to prevent gas tank explosions. in addition, it provides maintenance services to both external and in-house complex electronic systems and products. the company is headquartered in vancouver, canada.

Company info

SectorIndustrials
IndustryAerospace & Defense
Employees97
Market cap$19.8M

Fundamentals

Enterprise value$336.5M
Revenue$7.4M
Revenue per employee—
Profit margin27.71%
Debt to equity7.24

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.00
Dividend per share—
Revenue per share$0.29
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio—

Macro factor sensitivity

Growth+3.8
Credit+0.2
Liquidity-2.9
Inflation+2.2
Commodities+1.9
Interest Rates-2.8

Valuation

Dividend yield0.00%
PEG Ratio-20.16
Price to sales46.51
P/E Ratio-20.16
Enterprise Value to Revenue45.20
Price to book10.61

Upcoming events

Next earnings dayMay 17, 2022
Next dividend day—
Ex. dividend day—

News

AstraZeneca to invest $50 billion in the U.S. as pharma tariffs weigh

AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030.

CNBC (July 22, 2025)
AstraZeneca to invest $50B in US economy by 2030

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence in the company's largest market.

Fox Business (July 21, 2025)
AutoZone, Inc. (AZO) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to AutoZone (AZO). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research (July 21, 2025)
Will Lazard (LAZ) Beat Estimates Again in Its Next Earnings Report?

Lazard (LAZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research (July 18, 2025)
AstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage Studies

AZN's anselamimab fails to meet key goals in late-stage AL amyloidosis trials despite signs of subgroup benefit.

Zacks Investment Research (July 17, 2025)
Ouster vs. Luminar: Which LiDAR Powerhouse is a Safer Long-Term Play?

OUST shares surge 131.6% YTD while LAZR falls 47%, raising key questions for LiDAR investors choosing between them.

Zacks Investment Research (July 16, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free